Erectile Dysfunction and Cardiovascular Risk

Erectile dysfunction (ED) is a sexual-health problem and a clinical marker for systemic cardiovascular disease (CVD). The two share risk factors and mechanisms. Diagnosing ED is a useful moment to address cardiovascular risk, consider lifestyle change, and decide whether cardiac evaluation is needed before ED treatment.

Risk markers

A risk marker predicts higher probability of a disease state without necessarily lying on the causal pathway. ED is a risk marker for systemic CVD. Patient-facing overlap with other conditions is summarized in ED and other health conditions.

Relationship between ED and CVD

The link was first framed around shared clinical risk factors — hypertension, smoking, and diabetes — and shared mechanisms such as inflammation, endothelial dysfunction, and atherosclerosis. From the early 2000s, studies showed a bidirectional association: men with CVD are more likely to have ED, and men with ED have a higher risk of later CVD.

Key research findings

The Princeton Consensus Conference identified ED as a significant independent risk marker for CVD. In the Prostate Cancer Prevention Trial (Thompson et al., JAMA, 2005), ED predicted future cardiac events about as strongly as cigarette smoking or a family history of myocardial infarction. The QRISK group later included ED as an independent factor in its 10-year cardiovascular risk model, QRISK3, where ED was associated with a 25% higher risk at the mean age of the study population (Hippisley-Cox, Coupland, and Brindle, BMJ, 2017).

ED diagnosis as a lifestyle intervention point

Finding ED is a practical time to review cardiovascular risk and lifestyle. Changes that lower vascular risk can also improve erectile function. Sexual activity itself carries a small absolute cardiac risk; that risk is lower in men who are regularly active, but it is not zero.

When cardiac evaluation precedes ED treatment

If fitness for sexual activity is uncertain, cardiology evaluation is appropriate. The Princeton III criteria provide a framework for deciding when cardiac assessment should come before ED treatment. Low-risk men — those without cardiac symptoms, or those who have had successful cardiac revascularization or similar procedures — can usually be treated for ED without further cardiovascular testing. Men with other cardiovascular conditions need specialist input first.

The AUA Erectile Dysfunction Guideline treats ED as a CVD risk marker (Statement 3, Clinical Principle). See also what the AUA guideline is and how urologists use it.

If you have questions about anything in this article, write to us at hello@xialla.com. We read and answer every message.